+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Influenza Vaccine Market Intelligence Report - Global Forecast to 2027

  • PDF Icon

    Report

  • 126 Pages
  • July 2022
  • Region: Global
  • Think Market Intelligence
  • ID: 5624326
UP TO OFF until Dec 31st 2022
The Global Influenza Vaccine Market is projected to reach USD 11,141.69 million by 2027 from USD 6,705.34 million in 2021, at a CAGR of 8.83% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available.

In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

  • The Americas Influenza Vaccine Market size was estimated at USD 2,253.85 million in 2021 and expected to reach USD 2,457.08 million in 2022, at a CAGR of 8.96% to reach USD 3,771.93 million by 2027.
  • The Asia-Pacific Influenza Vaccine Market size was estimated at USD 1,874.81 million in 2021 and expected to reach USD 2,047.18 million in 2022, at a CAGR of 9.02% to reach USD 3,148.36 million by 2027.
  • The Europe, Middle East & Africa Influenza Vaccine Market size was estimated at USD 2,576.68 million in 2021 and expected to reach USD 2,781.08 million in 2022, at a CAGR of 8.57% to reach USD 4,221.39 million by 2027.

Market Segmentation & Coverage:

The report on influenza vaccine identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the influenza vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:

Vaccine Type:

  • Inactivated
  • Live Attenuated
  • Recombinant

Age Group:

  • Adolescent Vaccination
  • Adult Vaccination
  • Infant Vaccination

Administration Route:

  • Intramuscular
  • Intranasal
  • Oral

Distribution Channel:

  • Government Medical Office
  • Hospital & Clinic
  • Retail Pharmacy
  • Urgent Care Unit

Region:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

Company Usability Profiles:

  • Abbott Laboratories
  • AstraZeneca PLC
  • Bayer AG
  • BioDiem
  • BiondVax Pharmaceuticals Ltd.
  • Bristol-Myers Squibb Company
  • CanSino Biologics Inc.
  • Daiichi Sankyo Company, Limited
  • Emergent BioSolutions Inc.
  • Eurocept Group
  • Fluart Innovative Vaccines Kft.
  • Gamma Vaccines Pty Ltd
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Seqirus GmbH
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Swedish Orphan Biovitrum AB
Frequently Asked Questions about the Global Influenza Vaccine Market

What is the estimated value of the Global Influenza Vaccine Market?

The Global Influenza Vaccine Market was estimated to be valued at $6705.34 Million in 2021.

What is the growth rate of the Global Influenza Vaccine Market?

The growth rate of the Global Influenza Vaccine Market is 8.8%, with an estimated value of $11141.69 Million by 2027.

What is the forecasted size of the Global Influenza Vaccine Market?

The Global Influenza Vaccine Market is estimated to be worth $11141.69 Million by 2027.

Who are the key companies in the Global Influenza Vaccine Market?

Key companies in the Global Influenza Vaccine Market include Abbott Laboratories, AstraZeneca PLC, Bayer AG, BioDiem, BiondVax Pharmaceuticals Ltd., Bristol, Myers Squibb Company, CanSino Biologics Inc. and Emergent BioSolutions Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Market Overview
4. Influenza Vaccine Market, by Vaccine Type
4.1. Introduction
4.2. Inactivated
4.3. Live Attenuated
4.4. Recombinant
5. Influenza Vaccine Market, by Age Group
5.1. Introduction
5.2. Adolescent Vaccination
5.3. Adult Vaccination
5.4. Infant Vaccination
6. Influenza Vaccine Market, by Administration Route
6.1. Introduction
6.2. Intramuscular
6.3. Intranasal
6.4. Oral
7. Influenza Vaccine Market, by Distribution Channel
7.1. Introduction
7.2. Government Medical Office
7.3. Hospital & Clinic
7.4. Retail Pharmacy
7.5. Urgent Care Unit
8. Company Usability Profiles
8.1. Abbott Laboratories
8.1.1. Business Overview
8.1.2. Key Executives
8.1.3. Product & Services
8.2. AstraZeneca PLC
8.2.1. Business Overview
8.2.2. Key Executives
8.2.3. Product & Services
8.3. Bayer AG
8.3.1. Business Overview
8.3.2. Key Executives
8.3.3. Product & Services
8.4. BioDiem
8.4.1. Business Overview
8.4.2. Key Executives
8.4.3. Product & Services
8.5. BiondVax Pharmaceuticals Ltd.
8.5.1. Business Overview
8.5.2. Key Executives
8.5.3. Product & Services
8.6. Bristol-Myers Squibb Company
8.6.1. Business Overview
8.6.2. Key Executives
8.6.3. Product & Services
8.7. CanSino Biologics Inc.
8.7.1. Business Overview
8.7.2. Key Executives
8.7.3. Product & Services
8.8. Daiichi Sankyo Company, Limited
8.8.1. Business Overview
8.8.2. Key Executives
8.8.3. Product & Services
8.9. Emergent BioSolutions Inc.
8.9.1. Business Overview
8.9.2. Key Executives
8.9.3. Product & Services
8.10. Eurocept Group
8.10.1. Business Overview
8.10.2. Key Executives
8.10.3. Product & Services
8.11. Fluart Innovative Vaccines Kft.
8.11.1. Business Overview
8.11.2. Key Executives
8.11.3. Product & Services
8.12. Gamma Vaccines Pty Ltd
8.12.1. Business Overview
8.12.2. Key Executives
8.12.3. Product & Services
8.13. GlaxoSmithKline PLC
8.13.1. Business Overview
8.13.2. Key Executives
8.13.3. Product & Services
8.14. Johnson & Johnson
8.14.1. Business Overview
8.14.2. Key Executives
8.14.3. Product & Services
8.15. Merck & Co., Inc.
8.15.1. Business Overview
8.15.2. Key Executives
8.15.3. Product & Services
8.16. Pfizer Inc.
8.16.1. Business Overview
8.16.2. Key Executives
8.16.3. Product & Services
8.17. Sanofi S.A.
8.17.1. Business Overview
8.17.2. Key Executives
8.17.3. Product & Services
8.18. Seqirus GmbH
8.18.1. Business Overview
8.18.2. Key Executives
8.18.3. Product & Services
8.19. Serum Institute of India Pvt. Ltd.
8.19.1. Business Overview
8.19.2. Key Executives
8.19.3. Product & Services
8.20. Sinovac Biotech Ltd.
8.20.1. Business Overview
8.20.2. Key Executives
8.20.3. Product & Services
8.21. Swedish Orphan Biovitrum AB
8.21.1. Business Overview
8.21.2. Key Executives
8.21.3. Product & Services
9. Appendix
9.1. Discussion Guide
9.2. License & Pricing
List of Figures
Figure 1. Global Influenza Vaccine Market: Research Process
Figure 2. Global Influenza Vaccine Market Size, 2019-2027 (USD Million)
Figure 3. Global Influenza Vaccine Market Size, by Region, 2021 Vs 2027 (%)
Figure 4. Global Influenza Vaccine Market Size, by Region, 2021 Vs 2027 (USD Million)
Figure 5. Global Influenza Vaccine Market Competitive Strategic Window, by Region, 2027
Figure 6. Global Influenza Vaccine Market Size, by Country, 2021 Vs 2027 (%)
Figure 7. Global Influenza Vaccine Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 8. Global Influenza Vaccine Market Competitive Strategic Window, by Country, 2027
Figure 9. Global Influenza Vaccine Market Size, by Vaccine Type, 2021 Vs 2027 (%)
Figure 10. Global Influenza Vaccine Market Size, by Vaccine Type, 2021 Vs 2027 (USD Million)
Figure 11. Global Influenza Vaccine Market Competitive Strategic Window, by Vaccine Type, 2027
Figure 12. Global Influenza Vaccine Market Size, by Inactivated, 2019-2027 (USD Million)
Figure 13. Global Influenza Vaccine Market Size, by Live Attenuated, 2019-2027 (USD Million)
Figure 14. Global Influenza Vaccine Market Size, by Recombinant, 2019-2027 (USD Million)
Figure 15. Global Influenza Vaccine Market Size, by Age Group, 2021 Vs 2027 (%)
Figure 16. Global Influenza Vaccine Market Size, by Age Group, 2021 Vs 2027 (USD Million)
Figure 17. Global Influenza Vaccine Market Competitive Strategic Window, by Age Group, 2027
Figure 18. Global Influenza Vaccine Market Size, by Adolescent Vaccination, 2019-2027 (USD Million)
Figure 19. Global Influenza Vaccine Market Size, by Adult Vaccination, 2019-2027 (USD Million)
Figure 20. Global Influenza Vaccine Market Size, by Infant Vaccination, 2019-2027 (USD Million)
Figure 21. Global Influenza Vaccine Market Size, by Administration Route, 2021 Vs 2027 (%)
Figure 22. Global Influenza Vaccine Market Size, by Administration Route, 2021 Vs 2027 (USD Million)
Figure 23. Global Influenza Vaccine Market Competitive Strategic Window, by Administration Route, 2027
Figure 24. Global Influenza Vaccine Market Size, by Intramuscular, 2019-2027 (USD Million)
Figure 25. Global Influenza Vaccine Market Size, by Intranasal, 2019-2027 (USD Million)
Figure 26. Global Influenza Vaccine Market Size, by Oral, 2019-2027 (USD Million)
Figure 27. Global Influenza Vaccine Market Size, by Distribution Channel, 2021 Vs 2027 (%)
Figure 28. Global Influenza Vaccine Market Size, by Distribution Channel, 2021 Vs 2027 (USD Million)
Figure 29. Global Influenza Vaccine Market Competitive Strategic Window, by Distribution Channel, 2027
Figure 30. Global Influenza Vaccine Market Size, by Government Medical Office, 2019-2027 (USD Million)
Figure 31. Global Influenza Vaccine Market Size, by Hospital & Clinic, 2019-2027 (USD Million)
Figure 32. Global Influenza Vaccine Market Size, by Retail Pharmacy, 2019-2027 (USD Million)
Figure 33. Global Influenza Vaccine Market Size, by Urgent Care Unit, 2019-2027 (USD Million)
List of Tables
Table 1. Global Influenza Vaccine Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2019-2021
Table 3. Global Influenza Vaccine Market Size, 2019-2027 (USD Million)
Table 4. Global Influenza Vaccine Market Size, by Region, 2019-2027 (USD Million)
Table 5. Global Influenza Vaccine Market Size, by Country, 2019-2027 (USD Million)
Table 6. Global Influenza Vaccine Market Size, by Vaccine Type, 2019-2027 (USD Million)
Table 7. Global Influenza Vaccine Market Size, by Inactivated, 2019-2027 (USD Million)
Table 8. Global Influenza Vaccine Market Size, by Inactivated, by Region, 2019-2027 (USD Million)
Table 9. Global Influenza Vaccine Market Size, by Inactivated, by Region, 2019-2027 (USD Million)
Table 10. Global Influenza Vaccine Market Size, by Live Attenuated, 2019-2027 (USD Million)
Table 11. Global Influenza Vaccine Market Size, by Live Attenuated, by Region, 2019-2027 (USD Million)
Table 12. Global Influenza Vaccine Market Size, by Live Attenuated, by Region, 2019-2027 (USD Million)
Table 13. Global Influenza Vaccine Market Size, by Recombinant, 2019-2027 (USD Million)
Table 14. Global Influenza Vaccine Market Size, by Recombinant, by Region, 2019-2027 (USD Million)
Table 15. Global Influenza Vaccine Market Size, by Recombinant, by Region, 2019-2027 (USD Million)
Table 16. Global Influenza Vaccine Market Size, by Age Group, 2019-2027 (USD Million)
Table 17. Global Influenza Vaccine Market Size, by Adolescent Vaccination, 2019-2027 (USD Million)
Table 18. Global Influenza Vaccine Market Size, by Adolescent Vaccination, by Region, 2019-2027 (USD Million)
Table 19. Global Influenza Vaccine Market Size, by Adolescent Vaccination, by Region, 2019-2027 (USD Million)
Table 20. Global Influenza Vaccine Market Size, by Adult Vaccination, 2019-2027 (USD Million)
Table 21. Global Influenza Vaccine Market Size, by Adult Vaccination, by Region, 2019-2027 (USD Million)
Table 22. Global Influenza Vaccine Market Size, by Adult Vaccination, by Region, 2019-2027 (USD Million)
Table 23. Global Influenza Vaccine Market Size, by Infant Vaccination, 2019-2027 (USD Million)
Table 24. Global Influenza Vaccine Market Size, by Infant Vaccination, by Region, 2019-2027 (USD Million)
Table 25. Global Influenza Vaccine Market Size, by Infant Vaccination, by Region, 2019-2027 (USD Million)
Table 26. Global Influenza Vaccine Market Size, by Administration Route, 2019-2027 (USD Million)
Table 27. Global Influenza Vaccine Market Size, by Intramuscular, 2019-2027 (USD Million)
Table 28. Global Influenza Vaccine Market Size, by Intramuscular, by Region, 2019-2027 (USD Million)
Table 29. Global Influenza Vaccine Market Size, by Intramuscular, by Region, 2019-2027 (USD Million)
Table 30. Global Influenza Vaccine Market Size, by Intranasal, 2019-2027 (USD Million)
Table 31. Global Influenza Vaccine Market Size, by Intranasal, by Region, 2019-2027 (USD Million)
Table 32. Global Influenza Vaccine Market Size, by Intranasal, by Region, 2019-2027 (USD Million)
Table 33. Global Influenza Vaccine Market Size, by Oral, 2019-2027 (USD Million)
Table 34. Global Influenza Vaccine Market Size, by Oral, by Region, 2019-2027 (USD Million)
Table 35. Global Influenza Vaccine Market Size, by Oral, by Region, 2019-2027 (USD Million)
Table 36. Global Influenza Vaccine Market Size, by Distribution Channel, 2019-2027 (USD Million)
Table 37. Global Influenza Vaccine Market Size, by Government Medical Office, 2019-2027 (USD Million)
Table 38. Global Influenza Vaccine Market Size, by Government Medical Office, by Region, 2019-2027 (USD Million)
Table 39. Global Influenza Vaccine Market Size, by Government Medical Office, by Region, 2019-2027 (USD Million)
Table 40. Global Influenza Vaccine Market Size, by Hospital & Clinic, 2019-2027 (USD Million)
Table 41. Global Influenza Vaccine Market Size, by Hospital & Clinic, by Region, 2019-2027 (USD Million)
Table 42. Global Influenza Vaccine Market Size, by Hospital & Clinic, by Region, 2019-2027 (USD Million)
Table 43. Global Influenza Vaccine Market Size, by Retail Pharmacy, 2019-2027 (USD Million)
Table 44. Global Influenza Vaccine Market Size, by Retail Pharmacy, by Region, 2019-2027 (USD Million)
Table 45. Global Influenza Vaccine Market Size, by Retail Pharmacy, by Region, 2019-2027 (USD Million)
Table 46. Global Influenza Vaccine Market Size, by Urgent Care Unit, 2019-2027 (USD Million)
Table 47. Global Influenza Vaccine Market Size, by Urgent Care Unit, by Region, 2019-2027 (USD Million)
Table 48. Global Influenza Vaccine Market Size, by Urgent Care Unit, by Region, 2019-2027 (USD Million)
Table 49. Global Influenza Vaccine Market: License & Pricing

Companies Mentioned

  • Abbott Laboratories
  • AstraZeneca PLC
  • Bayer AG
  • BioDiem
  • BiondVax Pharmaceuticals Ltd.
  • Bristol-Myers Squibb Company
  • CanSino Biologics Inc.
  • Daiichi Sankyo Company, Limited
  • Emergent BioSolutions Inc.
  • Eurocept Group
  • Fluart Innovative Vaccines Kft.
  • Gamma Vaccines Pty Ltd
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Seqirus GmbH
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Swedish Orphan Biovitrum AB

Methodology

Loading
LOADING...